Study: Aspirin Early On Could Be Effective For COVID Patients

Scientists from George Washington University looked at medical data of more than 110,000 U.S. patients from 64 hospitals.

A single baby aspirin could be all the difference for someone hospitalized with COVID. 

Scientists from George Washington University looked at medical data of more than 110,000 U.S. patients from 64 hospitals. 

Those with moderate symptoms — meaning not in the ICU or on a ventilator — who took an aspirin in the first 24 hours, showed a lower risk of dying. Dr. Jonathan Chow led the study.